AngioDynamics to Hold Fiscal First Quarter Financial Results Conference Call on Thursday, October 7, 2004.QUEENSBURY, N.Y. -- AngioDynamics, Inc. (Nasdaq:ANGO ANGO Algemene Nederlandse Gehandicapten Organisatie (Dutch: Equal Opportunities for Persons with Disabilities) ) today announced that the company will release first quarter results on Thursday, October 7, 2004 after market close. Eamonn P. Hobbs, president and chief executive officer, and Joseph G. Gerardi, chief financial officer, will host an investment community conference call beginning at 4:30 p.m. Eastern Time on October 7th to discuss these results and to answer questions. To participate in the live call by telephone, please dial 888-804-7108 from the U.S., or for international callers, please dial 706-634-1250. Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations Investor relations The process by which the corporation communicates with its investors. section of AngioDynamics' web site at http://investor.angiodynamics.com/. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download, and install the necessary audio software. A replay will be available on the Web site for 14 days. A telephone replay will be available from 7:30 p.m. Eastern Time October 7, 2004 through 11:59 p.m. Eastern Time on October 9 by dialing 888-642-1687 (domestic) or 706-645-9291 (international) and entering conference ID number 1232115. About AngioDynamics AngioDynamics, Inc. designs, develops, manufactures and markets innovative medical devices used in minimally invasive, image-guided procedures to treat peripheral vascular disease Peripheral Vascular Disease Definition Peripheral vascular disease is a narrowing of blood vessels that restricts blood flow. It mostly occurs in the legs, but is sometimes seen in the arms. . It offers a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. AngioDynamics' diversified product line includes angiographic catheters, hemodialysis catheters, PTA PTA or parent-teacher association: see parent education. dilation dilation /di·la·tion/ (di-la´shun) 1. the act of dilating or stretching. 2. dilatation. di·la·tion n. 1. catheters, thrombolytic thrombolytic /throm·bo·lyt·ic/ (throm?bo-lit´ik) dissolving or splitting up a thrombus, or an agent that so acts. thrombolytic 1. dissolving or splitting up a thrombus. 2. an agent that dissolves or splits up a thrombus. products, image-guided vascular access vascular access Clinical medicine The ability to enter the vascular system; the ease with which the vascular system can be entered for administering therapy or obtaining blood for testing products, endovascular laser venous system products, as well as drainage products. AngioDynamics is a majority-owned subsidiary of E-Z-EM, Inc. (AMEX AMEX See: American Stock Exchange :EZM), a leading manufacturer of contrast agents for gastrointestinal radiology. The statements made in this document contain certain forward-looking statements that involve a number of risks and uncertainties. Words such as "expects," "intends," "anticipates," "plans," "believes," "seeks," "estimates," or variations of such words and similar expressions, are intended to identify such forward-looking statements. Investors are cautioned that actual events or results may differ from the Company's expectations. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion